Fosinoprilum natricum, Hydrochlorothiazidum
Medicinal product name | Fosinopril HCT Actavis 20 mg/12.5 mg tablets |
||||||
---|---|---|---|---|---|---|---|
Pharmaceutical form | Tablet | ||||||
Strength | 20 mg/12.5 mg | ||||||
Information from the MAH on shortages |
planned withdraw date: May 7, 2024 |
||||||
Availability of medicinal product |
|
||||||
Legal status | Reimbursed medicines reference product |
Prescription (Pr.)||||||
Package leaflet | 12-10-2023 | ||||||
Summary of product characteristics | 12-10-2023 | ||||||
Risk minimisation measures | Vēstule veselības aprūpes speciālistam | ||||||
ATC code | C09BA09 – Agents acting on the renin-angiotensin system | ||||||
Information for Marketing authorisation holders | View |
Medicinal products (7)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (20 mg/12,5 mg) |
Al/Al blister | 07-0082-01 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
Is available (according to the information provided by wholesalers) (734 containers) planned withdraw date: May 7, 2024 |
Tamro, Recipe Plus, Magnum Medical, Baltfarm "Vita-Farm", Euroaptieka, Oribalt Rīga |
N30 (20 mg/12,5 mg) |
Al/Al blister |
€ 6.91 * |
07-0082-02 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (20 mg/12,5 mg) |
Al/Al blister | 07-0082-03 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (20 mg/12,5 mg) |
Al/Al blister | 07-0082-04 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (20 mg/12,5 mg) |
Al/Al blister | 07-0082-05 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (20 mg/12,5 mg) |
Al/Al blister | 07-0082-06 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (20 mg/12,5 mg) |
Al/Al blister | 07-0082-07 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
Registration information
Marketing authorisation No. | 07-0082 |
---|---|
Date of authorisation | Mar 14, 2007 |
Marketing authorisation holder, country | Teva B.V., Netherlands |